The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
OXALIPLATINE Anaphylactic shock 1
OXALIPLATINE Blood creatine phosphokinase increased 1
OXALIPLATINE Bronchospasm 1
OXALIPLATINE Colorectal cancer 1
OXALIPLATINE Hypotension 1
OXALIPLATINE Multiple organ dysfunction syndrome 1
OXALIPLATINE Pneumonia 1
OXALIPLATINE Pulmonary embolism 1
OXALIPLATINE Pulmonary haemorrhage 1
OXALIPLATINE Pyrexia 1
OXALIPLATINE Rash erythematous 1
OXALIPLATINE Seizure 1
OXALIPLATINE Septic shock 1
OXALIPLATINE HOSPIRA Febrile bone marrow aplasia 1
OXALIPLATINE HOSPIRA Off label use 1
OXALIPLATINE KABI Neutropenia 1
OXALIPLATINE TEVA 5 mg/ml Arrhythmia 1
OXALIPLATINE TEVA 5 mg/ml Formication 1
OXALIPLATINE TEVA 5 mg/ml Muscle tightness 1
OXALIPLATINE TEVA 5 mg/ml Paraesthesia 1

Total Records: 864     Number of Pages: 44